Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 4, 2013, Pages

  Unemo, Magnus ^a   Ison, Catherine A ^b   Cole, Michelle ^b   Spiteri, Gianfranco ^c   Van De Laar, Marita ^c   Khotenashvili, Lali ^d  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CASE MANAGEMENT; CHLAMYDIASIS; DISEASE PREVENTION AND CONTROL; DISEASE SURVEILLANCE; ETHNIC GROUP; EUROPEAN GONOCOCCAL ANTIMICROBIAL SURVEILLANCE PROGRAM; EUROPEAN UNION; EVIDENCE BASED PRACTICE; GONORRHEA; HEALTH CARE SURVEY; HUMAN; LABORATORY DIAGNOSIS; MEDICAL SOCIETY; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SENTINEL SURVEILLANCE; TREATMENT FAILURE; TRICHOMONIASIS; USSR; WORLD HEALTH ORGANIZATION;

ANTIBIOTIC RESISTANCE; GONOCOCCI; GONORRHOEA; SURVEILLANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; EUROPE; EUROPEAN UNION; GONORRHEA; HEALTH POLICY; HUMANS; INFORMATION SERVICES; NEISSERIA GONORRHOEAE; WORLD HEALTH ORGANIZATION;

EID: 84891887000     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050909     Document Type: Article

References (41)

1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
2. Stoltey JE, Barry PM. The use of cephalosporins for gonorrhea: An update on the rising problem of resistance. Expert Opin Pharmacother 2012;13:1411-20.
3. Lewis DA. The gonococcus fights back: Is this time a knock out? Sex Transm Infect 2010;86:415-21.
4. Cole MJ, Unemo M, Hoffmann S, et al. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011;16:pii=19995.
5. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012;7:1401-22.
6. Van de Laar M, Spiteri G. Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. Euro Surveill 2012;17:pii=20225.
7. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011;16:p11=19792.
8. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55:3538-45.
9. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime-and ceftriaxone-resistant N. gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012;56:1273-80.
10. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010;15:pii=19721.
11. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011;16:pii=19833.
12. Unemo M, Golparian D, Stary A, et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria. Euro Surveill 2011;16:pii=19998.
13. Unemo M, Golparian D, Potočnik M, et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill 2012;17:pii=20200.
14. Lewis DA, Sriruttan C, Müller EE, et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin- resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother 2013;68:1267-70.
15. Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013;309:163-70.
16. Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment of gonorrhea. Emerg Infect Dis 2007;13:1275-7.
17. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012;67:1858-60.
18. World Health Organization (WHO). Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO, 2012:1-36. http://www.who. int/reproductivehealth/publications/rtis/9789241503501 (accessed 15 Aug 2013).
19. Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: The pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012;88:317-18.
20. European Centre for Disease Prevention and Control (ECDC). Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC, 2012:1-23. http://www.ecdc.europa.eu/en/publications/ Publications/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (accessed 15 Aug 2013).
21. Centers for Disease Control and Prevention (CDC). Cephalosporin-resistant Neisseria gonorrhoeae public health response plan. 2012:1-43. http://www.cdc.gov/std/gonorrhea/default.htm (accessed 15 Aug 2013).
22. World Health Organization (WHO). Prevalence and incidence of selected sexually transmitted infections: Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. Methods and results used by WHO to generate 2005 estimates. Geneva: World Health Organization, 2011. http://www.who.int/ reproductivehealth/publications/rtis/9789241502450/en/(accessed 15 Aug 2013).
23. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization, 2012. http://www.who.int/reproductivehealth/publications/rtis/2008-STI- estimates.pdf (accessed 15 Aug 2013).
24. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe, 1990-2010. Stockholm: ECDC, 2012. http://www.ecdc.europa. eu/en/publications/Publications/201206-Sexually- Transmitted-Infections-Europe-2010.pdf (accessed 15 Aug 2013).
25. Unemo M, Shipitsyna E, Domeika M; on behalf of the Eastern European Sexual and Reproductive Health (EE SRH) Network Antimicrobial Resistance Group. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: Implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial. Sex Transm Infect 2010;86: 442-4.
26. Unemo M, Shipitsyna E, Domeika M; the Eastern European Sexual and Reproductive Health (EE SRH) Network Antimicrobial Resistance Group. Gonorrhoea surveillance, laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae in 11 countries of the eastern part of the WHO European region. APMIS 2011;119:643-9.
27. GRASP Steering Group. The gonococcal resistance to antimicrobials programme (GRASP) year 2010 report. London: Health Protection Agency, 2011. http://www. hpa.org.uk/webc/HPAwebFile/HPAweb-C/1316016752917 (accessed 15 Aug 2013).
28. Risley CL, Ward H, Choudhury B, et al. Geographical and demographic clustering of gonorrhoea in London. Sex Transm Infect 2007;83:481-7. (Pubitemid 350043742)
29. Kubanova A, Frigo N, Kubanov A, et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendation of first-line antimicrobials for gonorrhoea treatment in Russia. Sex Transm Infect 2008;84:285-9.
30. Kubanova A, Frigo N, Kubanov A, et al. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)-national resistance prevalence in 2007 and 2008, and trends during 2005-2008. Euro Surveill 2010;15:pii=19533.
31. Glazkova S, Golparian D, Titov L, et al. Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus. APMIS 2011;119:537-42.
32. World Health Organization and UNAIDS. Strategies and laboratory methods for strengthening surveillance of sexually transmitted infection 2012. Appendix 3. Geneva, Switzerland: World Health Organization, 2012. http://www.who.int/ reproductivehealth/publications/rtis/9789241504478/en/index.html (accessed 15 Aug 2013).
33. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010;86:427-32.
34. Chisholm SA, Unemo M, Quaye N, et al. Molecular epidemiological typing within the European gonococcal antimicrobial resistance surveillance programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013;18:pii=20358.
35. Chisholm SA, Quaye N, Cole MJ, et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother 2011;66:592-5.
36. Unemo M, Fasth O, Fredlund H, et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009;63: 1142-51.
37. Frigo N, Unemo M, Kubanova A, et al. Russian gonococcal susceptibility programme (RU-GASP)-resistance levels in 2010 and trends during 2005-2010. Poster P1.S1.42 presented at the 19th biennial conference of the International Society for sexually transmitted diseases Research. Québec City, Canada, 10-13 July 2011.
38. Domeika M, Savicheva A, Sokolovskiy E, et al. Quality enhancements and quality assurance of laboratory diagnosis of sexually transmitted infections in Eastern Europe. Int J STD AIDS 2009;20:365-7.
39. Savicheva A, Sokolovsky E, Frigo N, et al. Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 1: Gonorrhoea, sampling, and microscopy for diagnosis. Acta Medica Lituanica 2007;14:65-74.
40. Savicheva A, Sokolovsky E, Frigo N, et al. Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 2: Culture, non-culture methods, determination of antibiotic resistance, and quality assurance. Acta Medica Lituanica 2007;14:123-34.
41. Domeika M, Savicheva A, Sokolovskiy E, et al. Guidelines for laboratory diagnosis of Neisseria gonorrhoeae infections in Eastern European countries-results of an international collaboration. Euro Surveill 2007;12:E071206.3.